Risk-Based Monitoring

The concept of risk-based monitoring (RbM) is evolving, as nonprofit organizations continue to collaborate with the biopharmaceutical/medical device industry to investigate, pilot and implement RbM practices.

Redefining this paradigm may help dispel current misperceptions around RBM and better deliver on the promise of this growing approach.

While capable of conducting high-quality trials, the current oversight process can be expensive and inefficient.

Steve Powell, PRA Executive VP Clinical Informatics and Late Phase Services Talks About Risk-Based Monitoring (RBM)

True efficiency requires the move to a company-wide ECM solution that supports the entire content lifecycle.